-
Polyganics Achieves CE Mark Certification for LIQOSEAL?
b3cnewswire
January 16, 2020
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has obtained CE marking for?LIQOSEAL?, its easy-to-use and innovative dural sealant patch ...
-
Polyganics Initiates First-in-Human Trial of LIQOSEAL?, its Innovative Approach for Dural Closure
b3cnewswire
November 10, 2018
The trial, titled ‘ENCASE’, is a single-arm, open-label study, evaluating safety and performance of LIQOSEAL? in reducing CSF leakage following elective cranial surgery. Up to 40 adult patients will be recruited at three sites across the Netherlands and S
-
Polyganics Initiates First-in-Human Trial of LIQOSEAL?, its Innovative Approach for Dural Closure
b3cnewswire
November 10, 2018
The trial, titled ‘ENCASE’, is a single-arm, open-label study, evaluating safety and performance of LIQOSEAL? in reducing CSF leakage following elective cranial surgery. Up to 40 adult patients will be recruited at three sites across the Netherlands and S
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
